111 related articles for article (PubMed ID: 15177461)
1. Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.
Hale JJ; Doherty G; Toth L; Mills SG; Hajdu R; Keohane CA; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Forrest M; Sun SY; West S; Xie H; Nomura N; Rosen H; Mandala S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3501-5. PubMed ID: 15177461
[TBL] [Abstract][Full Text] [Related]
2. The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists.
Hale JJ; Doherty G; Toth L; Li Z; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3495-9. PubMed ID: 15177460
[TBL] [Abstract][Full Text] [Related]
3. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
[TBL] [Abstract][Full Text] [Related]
4. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies.
Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA
Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
Clemens JJ; Davis MD; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate (S1P) induces shape change in rat C6 glioma cells through the S1P2 receptor: development of an agonist for S1P receptors.
Kim K; Kim YL; Sacket SJ; Kim HL; Han M; Park DS; Lee BK; Lee WK; Ha HJ; Im DS
J Pharm Pharmacol; 2007 Jul; 59(7):1035-41. PubMed ID: 17637200
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
Sanna MG; Wang SK; Gonzalez-Cabrera PJ; Don A; Marsolais D; Matheu MP; Wei SH; Parker I; Jo E; Cheng WC; Cahalan MD; Wong CH; Rosen H
Nat Chem Biol; 2006 Aug; 2(8):434-41. PubMed ID: 16829954
[TBL] [Abstract][Full Text] [Related]
8. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis.
Li QF; Wu CT; Guo Q; Wang H; Wang LS
Biochem Biophys Res Commun; 2008 Jun; 371(1):159-62. PubMed ID: 18423379
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
Kohno T; Igarashi Y
Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.
Whetzel AM; Bolick DT; Srinivasan S; Macdonald TL; Morris MA; Ley K; Hedrick CC
Circ Res; 2006 Sep; 99(7):731-9. PubMed ID: 16960101
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
Yan L; Hale JJ; Lynch CL; Budhu R; Gentry A; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala SM
Bioorg Med Chem Lett; 2004 Oct; 14(19):4861-6. PubMed ID: 15341940
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold.
Koide Y; Uemoto K; Hasegawa T; Sada T; Murakami A; Takasugi H; Sakurai A; Mochizuki N; Takahashi A; Nishida A
J Med Chem; 2007 Feb; 50(3):442-54. PubMed ID: 17266196
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM
Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate signaling in the cardiovascular system.
Peters SL; Alewijnse AE
Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
[TBL] [Abstract][Full Text] [Related]
18. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.
Hale JJ; Lynch CL; Neway W; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Parent SA; Chrebet G; Bergstrom J; Card D; Ferrer M; Hodder P; Strulovici B; Rosen H; Mandala S
J Med Chem; 2004 Dec; 47(27):6662-5. PubMed ID: 15615513
[TBL] [Abstract][Full Text] [Related]
19. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
Huwiler A; Pfeilschifter J
Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons.
Zhang YH; Fehrenbacher JC; Vasko MR; Nicol GD
J Neurophysiol; 2006 Sep; 96(3):1042-52. PubMed ID: 16723416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
